For many decades, the foundations of cancer treatment have been surgery, chemotherapy, and radiation therapy. But, in recent years, a newer therapy in the form of immunotherapy has emerged, ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first myeloma patient with this therapy, resulting in a very good response without ...

Targeting these same signaling pathways may thus prove an effective disease treatment in humans, the researchers said. The research is particularly promising because drugs targeting plasma cells ...

1Genome Research Center, GC Genome, Yongin-si, South Korea. *Corresponding Author: Eun-Hae Cho, Genome Research Center, GC Genome, 107, Ihyeon-ro 30 beon-gil, Yongin-si, 16924, South Korea. E-mail: ...

This subsequently leads to aging and disease. Because of this, the removal of senescent cells is anticipated to facilitate treatment of age-related diseases, such as cancer. Identifying senescent ...

Division of Hematology, 1st Department of Internal Medicine, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece Plasma cell neoplasms include a spectrum of disorders ...

Chronic Myeloid Leukemia (CML ... on the number of immature white blood cells, called blasts, in a patient's blood and circulation. These are chronic, accelerated, and blast phases. These phases have ...

Thanks to new treatments, people with refractory multiple myeloma have more options and may live longer. In multiple myeloma, abnormal plasma cells multiply in your bone marrow — the soft ...

What if treating autoimmune diseases was as simple as regulating the acidity levels of parts of patients' cells? Genetic screening ... and there are few treatment options for it.